Preliminary safety data from a randomized trial of perioperative epirubicin, cisplatin plus capecitabine (ECX) with or without bevacizumab (B) in patients (pts) with gastric or oesophagogastric ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback